Virtual Screening in Drug Design and Development

被引：0
|
作者：
Sousa, Sergio F. [1 ]
Cerqueira, Nuno M. F. S. A. [1 ]
Fernandes, Pedro A. [1 ]
Ramos, Maria Joao [1 ]
机构：
[1] Univ Porto, REQUIMTE, Dept Quim, Fac Ciencias, P-4169007 Oporto, Portugal
来源：
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 2010年 / 13卷 / 05期
关键词：
Drug design; docking; scoring; filters; compound libraries; druggability; protein flexibility; computational chemistry; PROTEIN-COUPLED RECEPTORS; MOLECULAR DOCKING; CHEMICAL DATABASES; LEAD OPTIMIZATION; LIGAND DOCKING; DISCOVERY; FLEXIBILITY; STRATEGIES; INHIBITORS; BETA;
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Virtual screening (VS) is presently a key component in the process of drug design and development. VS is normally regarded as the selection of likely drug candidates from large libraries of chemical structures by using computational methodologies. However, the generic definition of VS is significantly wider and may encompass many different methods. This review tries to present a comprehensive overview of the virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, an introduction to the general types of virtual screening methodologies is presented. The main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. This analysis is complemented with a careful selection of VS success stories. Finally, a reflection on the future challenges of this promising methodology is drawn.
引用
收藏
页码：442 / 453
页数：12
相关论文
共 50 条
  • [31] Deep Belief Networks Using Hybrid Fingerprint Feature for Virtual Screening of Drug Design
    Fitriawan, Aries
    Wasito, Ito
    Syafiandini, Arida Ferti
    Amien, Mukhlis
    Yanuar, Arry
    2016 INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER SCIENCE AND INFORMATION SYSTEMS (ICACSIS), 2016, : 417 - 420
  • [32] Overview on the drug development process and molecular similarity-based virtual screening techniques
    Rivera Borroto, Oscar Miguel
    Hernandez Diaz, Yoandy
    Manuel Garcia de la Vega, Jose
    Grau, Ricardo
    Marrero Ponce, Yovani
    Cruz Monteagudo, Maikel
    ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA, 2013, 79 (04): : 530 - 561
  • [33] INTEGRATING VIRTUAL AND HIGH-THROUGHPUT SCREENING: OPPORTUNITIES AND CHALLENGES IN DRUG RESEARCH AND DEVELOPMENT
    Ferreira, Rafaela S.
    Oliva, Glaucius
    Andricopulo, Adriano D.
    QUIMICA NOVA, 2011, 34 (10): : 1770 - 1778
  • [34] The holistic integration of virtual screening in drug discovery
    Tanrikulu, Yusuf
    Krueger, Bjoern
    Proschak, Ewgenij
    DRUG DISCOVERY TODAY, 2013, 18 (7-8) : 358 - 364
  • [35] Virtual screening for fragment based drug discovery
    Yuan, Qiong
    Liu, Cynthia
    Winer, Fred
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [36] Recent advances in virtual screening for drug discovery
    Leung, Chung-Hang
    Ma, Dik-Lung
    METHODS, 2015, 71 : 1 - 3
  • [37] Integration of virtual screening into the drug discovery process
    Chin, DN
    Chuaqui, CE
    Singh, J
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (10) : 1053 - 1065
  • [38] Virtual screening in drug discovery - A computational perspective
    Reddy, A. Srinivas
    Pati, S. Priyadarshini
    Potukuchi, Praveen Kumar
    Pradeep, H. N.
    Sastry, G. Narahari
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (04) : 329 - 351
  • [39] The virtual heart as a platform for screening drug cardiotoxicity
    Yuan, Yongfeng
    Bai, Xiangyun
    Luo, Cunjin
    Wang, Kuanquan
    Zhang, Henggui
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (23) : 5531 - 5547
  • [40] Virtual Drug Screening Using Neural Networks
    Hagan, Davie M.
    Hagan, Martin T.
    2016 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), 2016, : 579 - 587
12345